(Q37329149)

19 August 2017

1 reference

title

Drug-eluting stent safety: findings from preclinical studies (English)

1 reference

19 August 2017

6

Frank D Kolodgie

1 reference

19 August 2017

2

Aloke V Finn

1 reference

19 August 2017

3

Elena Ladich

1 reference

19 August 2017

7

Renu Virmani

1 reference

19 August 2017

1

Gaku Nakazawa

1 reference

19 August 2017

4

Flavio Ribichini

1 reference

19 August 2017

Leslie Coleman

5

1 reference

PubMed ID

19018691

19 August 2017

language of work or name

1 reference

1 November 2008

1 reference

Expert Review of Cardiovascular Therapy

19 August 2017

1 reference

19 August 2017

6

1 reference

19 August 2017

10

1 reference

19 August 2017

1379-1391

1 reference

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

19 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Studies of drug-eluting stents: to each his own?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Outcomes and complications associated with off-label and untested use of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Stent thrombosis redux--the FDA perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

A comparison of bare-metal and drug-eluting stents for off-label indications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Drug eluting stents: are human and animal studies comparable?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation: insights from serial intravascular ultrasound analysis in the TAXUS II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Occupational allergies caused by latex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Toxicity of methyl methacrylate in dentistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Pathobiologic responses to stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Pathological analysis of local delivery of paclitaxel via a polymer-coated stent

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Endothelial cell recovery between comparator polymer-based drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Adjuvant therapy for intracoronary stents. Investigations in atherosclerotic swine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Pioglitazone inhibits in-stent restenosis in atherosclerotic rabbits by targeting transforming growth factor-beta and MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Effects of oral prednisone after stenting in a rabbit model of established atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Vascular responses to drug eluting stents: importance of delayed healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.6.10.1379

10.1586/14779072.6.10.1379

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19018691